Peer Review History
| Original SubmissionSeptember 16, 2019 |
|---|
|
PONE-D-19-26063 Multi-kinase control of environmental stress responsive transcription PLOS ONE Dear Dr. David Pincus, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== As you can see, the reviews are split on your manuscript. While Reviewer #1 provided a positive response, Reviewer #2 pointed out serious concerns about your study design in its current form. The reviewers had concerns especially about the lack of strain validation and the lack of biological repeats, which mitigate reliability and significance of the dataset. After considering all of the points raised by the reviewers, and having looked carefully at the manuscript itself, I have come to the conclusion that we can reconsider your manuscript if you could design further tests which enable to judge the validity of all the downstream analysis. ============================== We would appreciate receiving your revised manuscript by within three months. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Reiko Sugiura, M.D., PhD. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 1. Thank you for including the following funding information within the acknowledgements section of your manuscript; "This work was supported by NIGMS grant RO1 GM119033 to H.E.-S, NIH Early Independence Award DP5 OD017941 to D.P., and an International Student fellowship from HHMI to K.M" We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: No ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The paper by Mace and coworkers reports a study mostly based on transcriptomic data linking a set of protein kinases and their involvement in the stress response. This is a rather straightforward, sound, and well written study, which provides a huge amount of data and allow reaching interesting conclusions, such as the possible control of the PKA pathway by Pbs2/Hog1 tandem of kinases. I have no major problems with the paper, just a few minor points I would like the authors to consider. 1.- Line 84. The authors select 20 min as a standard time for all stress conditions. Now, the transcriptional response is intrinsically transient, and not all responses to all stresses display the same timing. Why 20 min was selected? I’m not saying this was a wrong choice (actually, I think it makes a lot of sense), but I feel the authors should provide the readers with a short explanation about why 20 min was a reasonable option. 2.- Figure 2B and others. I am not sure the color code is a good option for labeling the 28 different kinases in the figures. There are too many kinases and colors are often repeated (or they are so similar that you cannot tell them apart..), so they are useless. I’d suggest a code based on numbers (i.e. Atg1-1; Cdc15-2, ..and so on). Colors code for stresses would be OK, as they are only 10. 3.- Lines 173-183. These lines are confusing, because authors refer to Fig 3A when they are actually describing Fig 3B (tunicamycin treatment), Ire1 and Cdc15 mutants. The panels need relabeling. In addition, the fact that the order of stress conditions is different for each mutant makes comparisons not easy (this happens in both panels and the same occurs in fig. 6A) 4.- line 184-185. “inhibition of Cdc15 did not affect expression of a specific or dedicated regulon.”. I do have the impression that, in comparison to Ire1, the cdc15 mutant causes specific depletion of the amino acid metabolism GO group. Why the authors do not comment of that? Reviewer #2: Mace and colleagues have analysed the transcriptomes of 28 S. cerevisae strains each bearing an analogue sensitive mutations in a single kinase and cultivated in 10 different environmental conditions. Based on this dataset they report a series of observation on the role of certain kinases in the yeast response to environmental changes and follow up one observation using a GFP reporter and FACS analysis. It is a well written paper but I unfortunately have major concerns about the study design. 1) The report provides no evidence that each kinase is actually inactivated after analogue treatment. The authors must have checked their strains and confirmed that the mutations where indeed inactivating the enzymes in their experimental conditions. Why haven’t these data been included? Moreover, in their follow up experiments on figure 6 the authors perform experiments after 1 hour of inactivation and not 5 min. Why is that? The whole study is based on a 5min inactivation time. Without data about strain validation I find it very difficult to judge the validity of all the downstream analysis. What if some or most of the kinases weren't actually inactivated at the time of stress induction? 2) As far as I understand only one repeat of each treatment for each kinase has been performed. With this design I don’t think the authors can provide any statistical support to their analysis. They seem to have used DESeq2 for differential analysis, but I don’t think that using DESeq2 with only one experimental measurement is even statistically valid. Again, given this limitation I am not sure how solid this study conclusions actually are. 3) L84: “We harvested cells following 20 minutes in each environment”. Twenty minutes make sense for oxidative stress but how about glucose depletion for instance. Could the authors justify their choice of time point please? I am sorry that I cannot be more positive but without strain validation, a sense of the efficieny of kinase inactivation and given the lack of biological repeats, I really struggle to see how much can be learned from this dataset. This being said it would be a shame if these data were not made available to the community as they could help validating other large scale studies. I am not sure however that PLoS ONE is the right home for this. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Joaquin Ariño Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Multi-kinase control of environmental stress responsive transcription PONE-D-19-26063R1 Dear Dr. David Pincus, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Reiko Sugiura, M.D., PhD. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: (No Response) Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: (No Response) Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: (No Response) Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: (No Response) Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #2: I thank the authors for their replies. I am now reassured that most strains have been validated and understand the choice of experimental conditions better. In addition, given that the limitations of the design have now been clearly stated, I see no reason to delay the publication of this study further. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Joaquín Arino Reviewer #2: No |
| Formally Accepted |
|
PONE-D-19-26063R1 Multi-kinase control of environmental stress responsive transcription Dear Dr. Pincus: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Reiko Sugiura Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .